- $246.3M
1
- $113.3M
2
- <25<$5M
3
- $5.5M
4
- $67.5M
5
- 29$9.5M
6
WellSpring Consumer Health
Manufacturing · Florida, United States · 25 Employees
Founded in 1999, WellSpring Pharmaceutical Corporation is a privately held company which manufactures and markets a portfolio of well-recognized OTC brands that are widely distributed throughout the U.S. and Canada. Its prescription drug portfolio consists of brands that are recognized as highly effective therapies for certain niche patient populations. In addition, WellSpring is a contract manufacturing organization serving well-known U.S. pharmaceutical companies. Its wholly owned subsidiary operates an FDA and Health Canada inspected manufacturing plant in Oakville, Ontario, Canada. In October 2011, WellSpring was acquired by Sentinel and Ancor in partnership with its management team.Read More
View Company Info for Free
Who is WellSpring Consumer Health
Headquarters
Phone Number
Website
Revenue
Industry
Top Competitors of WellSpring Consumer Health
WellSpring Consumer Health Org Chart
WellSpring Consumer Health Company Metrics
-
Total Funding Amount
-
Most Recent Funding Amount
1
Number of Funding Rounds
Jul 06, 2016
Solarcaine
WellSpring Consumer Health
Bactine
See More Acquisitions & Subsidiaries
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
WellSpring Consumer Health News & Media
Audax Private Equity Completes the Sale of WellSpring Consumer Healthcare to Avista Capital Partners
BOSTON--(BUSINESS WIRE)--Audax Private Equity (“Audax”) today announced that it has completed the sale of WellSpring Consumer Healthcare (“WellSpring” or the “Company”) to Avista Capital Partners. Established in 1999 and headquartered in Sarasota, Florida, WellSpring is a leading marketer of iconic over-the-counter brands primarily in the skin care and gastrointestinal care categories. WellSpring’s product portfolio includes long-standing brands such as Bactine, Bonine, Emetrol, Glaxal Base, FDAvista buys consumer brands provider Wellspring Consumer Healthcare
The seller was Audax Private Equity.Avista picks up OTC drug developer Wellspring from Audax
‘The diversified and highly established nature of WellSpring’s product portfolio, coupled with a strong innovation pipeline and exciting growth opportunities in e-commerce, was very compelling,’ said Avista’s Lu.ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance
BAUDETTE, Minn., Nov. 6, 2018 /PRNewswire/ -- For the third quarter 2018: Record net revenues of $50.7 million, an increase of 5% as compared to the same period in 2017 GAAP net income of $5.0 million and diluted GAAP earnings per share of $0.42 Adjusted non-GAAP EBITDA of $21.4 million...
Frequently Asked Questions regarding WellSpring Consumer Health
Founded in 1999, WellSpring Pharmaceutical Corporation is a privately held company which manufactures and markets a portfolio of well-recognized OTC brands that are widely distributed throughout the U.S. and Canada. Its prescription drug portfolio consists of brands that are recognized as highly effective therapies for certain niche patient populat... Read More